Search

Issue
Title
Authors
Vol 16, No 3 (2014)
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.A.
Vol 20, No 3 (2018)
Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo
Novikov D.V., Polotskiy B.E., Bogush T.A., Davidov M.M., Ahmedov B.B., Rotobelskaya L.E.
PDF
(Rus)
Vol 15, No 1 (2013)
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
Kit O.I., Vladimirova L.Y., Sholokhova E.A.
Vol 21, No 3 (2019)
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer
Reutova E.V., Laktionov K.P., Iudin D.I., Neliubina L.A., Gorokhova G.K., Egorova A.V.
Vol 23, No 3 (2021)
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
Yudin D.I., Laktionov K.K., Laktionova L.V., Breder V.V.
PDF
(Rus)
Vol 23, No 3 (2021)
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features
Reutova E.V., Laktionov K.K.
PDF
(Rus)
Vol 20, No 3 (2018)
The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer
Karabina E.V., Lubchenko L.N., Garunov A.N.
PDF
(Rus)
Vol 22, No 3 (2020)
Detection of disseminated tumor cells and their relationship with a population of bone marrow lymphocytes in patients with non-small cell lung cancer
Djumanazarov T.M., Chulkova S.V., Tupitsyn N.N., Chernysheva O.A., Allakhverdiev A.K., Palladina A.D., Kupryshina N.A., Kolbatskaya O.P., Kononetz P.V., Akhmedov B.B., Gerasimov S.S.
PDF
(Rus)
Vol 19, No 2 (2017)
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.V.
PDF
(Rus)
Vol 22, No 3 (2020)
Molecular genetic portrait of non-small cell lung cancer in Tambov region: regional experience
Ognerubov N.A., Sychev V.D., Kozlova N.A., Chang V.L.
PDF
(Rus)
Vol 19, No 1 (2017)
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.V.
PDF
(Rus)
Vol 22, No 3 (2020)
Prospects for the development of adjuvant therapy for non-small cell lung cancer
Laktionov K.K., Kazakov A.M., Reutova E.V., Ardzinba M.S., Arzumanian A.L.
PDF
(Rus)
Vol 18, No 3 (2016)
Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene
Ryazhenov V.V., Gorokhova S.G.
PDF
(Rus)
Vol 22, No 2 (2020)
Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
Odintsova S.V., Sviridenko M.A., Cheremnykh A.O., Filippova E.A., Urtenova M.A., Orlov S.V.
PDF
(Rus)
Vol 22, No 2 (2020)
Adjuvant targeted therapy for non-small cell lung cancer
Laktionov K.K., Kazakov A.M., Gordiev M.G., Kononets P.V., Akhmedov B.B., Maevskaia J.N.
PDF
(Rus)
1 - 15 of 15 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies